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What is Ebola hemorrhagic fever?
E b o la  h e m o r rh a g ic  fe v e r  (E b o la  H F )  is a  s e v e r e , o f te n - fa ta l d is e a s e  in h u m a n s  a n d  n o n h u m a n  p r im a te s  (m o n k e y s , g o rilla s , 
a n d  c h im p a n z e e s )  th a t  h a s  a p p e a r e d  s p o ra d ic a lly  s in c e  its in itia l re c o g n it io n  in 1 9 7 6 . T h e  d is e a s e  is c a u s e d  b y  in fe c tio n  
w ith  E b o la  v iru s , n a m e d  a f te r  a  r iv e r  in th e  D e m o c r a t ic  R e p u b lic  o f  th e  C o n g o  ( fo r m e r ly  Z a ir e )  in A fr ic a , w h e r e  it w a s  firs t 
re c o g n iz e d . T h e  v iru s  is o n e  o f  tw o  m e m b e r s  o f  a  fa m ily  o f  R N A  v iru s e s  c a lle d  th e  F ilo v ir id a e . T h e r e  a r e  f iv e  id e n tif ie d  
s u b ty p e s  o f  E b o la  v iru s . F o u r  o f  th e  f iv e  h a v e  c a u s e d  d is e a s e  in h u m a n s : E b o la -Z a ir e ,  E b o la -S u d a n , E b o la - Iv o r y  C o a s t  a n d  
E b o la -B u n d ib u g y o . T h e  fifth , E b o la -R e s to n , h a s  c a u s e d  d is e a s e  in n o n h u m a n  p r im a te s , b u t n o t in h u m a n s .
Where is Ebola virus found in nature?
T h e  e x a c t  o r ig in , lo c a tio n s , a n d  n a tu ra l h a b ita t  (k n o w n  a s  th e  " n a tu ra l re s e rv o ir" )  o f  E b o la  v iru s  re m a in  u n k n o w n . H o w e v e r ,  
o n  th e  b a s is  o f  a v a i la b le  e v id e n c e  a n d  th e  n a tu re  o f  s im ila r  v iru s e s , r e s e a rc h e r s  b e lie v e  th a t  th e  v iru s  is z o o n o t ic  ( a n im a l­
b o rn e )  w ith  fo u r  o f  th e  f iv e  s u b ty p e s  o c c u rr in g  in a n  a n im a l h o s t n a t iv e  to  A fr ic a . A  s im ila r  h o s t, m o s t lik e ly  in th e  
P h ilip p in e s , is p ro b a b ly  a s s o c ia te d  w ith  th e  E b o la -R e s to n  s u b ty p e , w h ic h  w a s  is o la te d  fro m  in fe c te d  c y n o m o lg o u s  
m o n k e y s  th a t  w e r e  im p o rte d  to  th e  U n ite d  S ta te s  a n d  Ita ly  fro m  th e  P h ilip p in e s . T h e  v iru s  is n o t k n o w n  to  b e  n a t iv e  to  
o th e r  c o n tin e n ts , s u c h  a s  N o rth  A m e r ic a .
Where do cases of Ebola hemorrhagic fever occur?
C o n f irm e d  c a s e s  o f  E b o la  H F  h a v e  b e e n  re p o r te d  in th e  D e m o c r a t ic  R e p u b lic  o f  th e  C o n g o , G a b o n , S u d a n , th e  Iv o ry  C o a s t ,  
U g a n d a , a n d  th e  R e p u b lic  o f  th e  C o n g o . N o  c a s e  o f  th e  d is e a s e  in h u m a n s  h a s  e v e r  b e e n  re p o r te d  in th e  U n ite d  S ta te s .  
E b o la -R e s to n  v iru s  c a u s e d  s e v e r e  il ln e s s  a n d  d e a th  in m o n k e y s  im p o rte d  to  re s e a rc h  fa c ilit ie s  in th e  U n ite d  S ta te s  a n d  Ita ly  
fro m  th e  P h ilip p in e s ; d u rin g  th e s e  o u tb re a k s , s e v e r a l re s e a rc h  w o rk e r s  b e c a m e  in fe c te d  w ith  th e  v iru s , b u t d id  n o t b e c o m e  
ill.
E b o la  H F  ty p ic a lly  a p p e a r s  in s p o ra d ic  o u tb re a k s , u s u a lly  s p r e a d  w ith in  a  h e a lth -c a r e  s e tt in g  (a
s itu a tio n  k n o w n  a s  a m p lif ic a t io n ) . It is lik e ly  th a t  s p o ra d ic , is o la te d  c a s e s  o c c u r  a s  w e ll ,  b u t g o  u n re c o g n iz e d . A
ta b le  s h o w in g  a  c h ro n o lo g ic a l list o f  k n o w n  c a s e s  a n d  o u tb r e a k s  is a v a i la b le  b e lo w .
How is Ebola virus spread?
In fe c tio n s  w ith  E b o la  v iru s  a re  a c u te . T h e r e  is n o  c a r r ie r  s ta te . B e c a u s e  th e  n a tu ra l r e s e rv o ir  o f  th e  v iru s  is u n k n o w n , th e  
m a n n e r  in w h ic h  th e  v iru s  firs t a p p e a r s  in a  h u m a n  a t  th e  s ta r t  o f  a n  o u tb r e a k  h a s  n o t b e e n  d e te rm in e d . H o w e v e r ,  
r e s e a rc h e r s  h a v e  h y p o th e s iz e d  th a t  th e  firs t p a t ie n t  b e c o m e s  in fe c te d  th ro u g h  c o n ta c t  w ith  a n  in fe c te d  a n im a l.
A f te r  th e  firs t c a s e -p a t ie n t  in a n  o u tb r e a k  s e tt in g  is in fe c te d , th e  v iru s  c a n  b e  tr a n s m it te d  in s e v e r a l w a y s . P e o p le  c a n  be  
e x p o s e d  to  E b o la  v iru s  f ro m  d ire c t  c o n ta c t  w ith  th e  b lo o d  a n d /o r  s e c re t io n s  o f a n  in fe c te d  p e rs o n . T h u s , th e  v iru s  is o fte n  
s p re a d  th ro u g h  fa m ilie s  a n d  f r ie n d s  b e c a u s e  th e y  c o m e  in c lo s e  c o n ta c t  w ith  s u c h  s e c re t io n s  w h e n  c a r in g  fo r  in fe c te d  
p e rs o n s . P e o p le  c a n  a ls o  b e  e x p o s e d  to  E b o la  v iru s  th ro u g h  c o n ta c t  w ith  o b je c ts , s u c h  a s  n e e d le s , th a t  h a v e  b e e n  
c o n ta m in a te d  w ith  in fe c te d  s e c re t io n s .
N o s o c o m ia l tra n s m is s io n  r e fe rs  to  th e  s p r e a d  o f  a  d is e a s e  w ith in  a  h e a lth -c a r e  s e tt in g , s u c h  a s  a  c lin ic  o r  h o s p ita l. It o c c u rs  
f re q u e n t ly  d u rin g  E b o la  H F  o u tb re a k s . It in c lu d e s  b o th  ty p e s  o f  tra n s m is s io n  d e s c r ib e d  a b o v e . In A fr ic a n  h e a lth -c a r e  
fa c ilit ie s , p a t ie n ts  a r e  o fte n  c a re d  fo r  w ith o u t th e  u s e  o f  a  m a s k , g o w n , o r  g lo v e s . E x p o s u r e  to  th e  v iru s  h a s  o c c u rre d  w h e n  
h e a lth  c a r e  w o rk e r s  t r e a te d  in d iv id u a ls  w ith  E b o la  H F  w ith o u t w e a r in g  th e s e  ty p e s  o f  p ro te c t iv e  c lo th in g . In a d d it io n , w h e n  
n e e d le s  o r  s y r in g e s  a re  u s e d , th e y  m a y  n o t b e  o f  th e  d is p o s a b le  ty p e , o r  m a y  n o t h a v e  b e e n  s te r il iz e d , b u t o n ly  r in s e d  
b e fo re  re in s e rt io n  in to  m u lt i -u s e  v ia ls  o f  m e d ic in e . If n e e d le s  o r  s y r in g e s  b e c o m e  c o n ta m in a te d  w ith  v iru s  a n d  a r e  th e n  
r e u s e d , n u m e ro u s  p e o p le  c a n  b e c o m e  in fe c te d .
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How is Ebola virus spread? (continued)
E b o la -R e s to n  a p p e a r e d  in a  p r im a te  re s e a rc h  fa c ility  in V irg in ia , w h e r e  it m a y  h a v e  b e e n  t ra n s m it te d  fro m  m o n k e y  to  
m o n k e y  th ro u g h  th e  a ir . W h ile  a ll E b o la  v iru s  s p e c ie s  h a v e  d is p la y e d  th e  a b ility  to  b e  s p r e a d  th ro u g h  a irb o rn e  p a rtic le s  
(a e r o s o ls )  u n d e r  re s e a rc h  c o n d it io n s , th is  ty p e  o f  s p r e a d  h a s  n o t b e e n  d o c u m e n te d  a m o n g  h u m a n s  in a  re a l-w o r ld  s e tt in g , 
s u c h  a s  a  h o s p ita l o r  h o u s e h o ld .
What are the symptoms of Ebola hemorrhagic fever?
T h e  in c u b a tio n  p e r io d  fo r  E b o la  H F  ra n g e s  f ro m  2  to  21  d a y s . T h e  o n s e t  o f  il ln e s s  is a b ru p t  a n d  is c h a ra c te r iz e d  by  
fe v e r , h e a d a c h e , jo in t  a n d  m u s c le  a c h e s , s o re  th ro a t, a n d  w e a k n e s s ,  fo llo w e d  b y  d ia r r h e a , v o m it in g , a n d  s to m a c h  p a in .
A  ra s h , red  e y e s , h ic c u p s  a n d  in te rn a l a n d  e x te r n a l b le e d in g  m a y  b e  s e e n  in s o m e  p a tie n ts .
R e s e a r c h e r s  d o  n o t u n d e rs ta n d  w h y  s o m e  p e o p le  a re  a b le  to  r e c o v e r  fro m  E b o la  H F  a n d  o th e rs  a re  no t. H o w e v e r , it is 
k n o w n  th a t  p a t ie n ts  w h o  d ie  u s u a lly  h a v e  n o t d e v e lo p e d  a  s ig n if ic a n t  im m u n e  r e s p o n s e  to  th e  v iru s  a t  th e  t im e  o f  d e a th .
How is Ebola hemorrhagic fever clinically diagnosed?
D ia g n o s in g  E b o la  H F  in a n  in d iv id u a l w h o  h a s  b e e n  in fe c te d  o n ly  a  fe w  d a y s  is d iffic u lt b e c a u s e  e a r ly  s y m p to m s , s u c h  a s  
red  e y e s  a n d  a  s k in  ra s h , a re  n o n s p e c if ic  to  th e  v iru s  a n d  a r e  s e e n  in o th e r  p a t ie n ts  w ith  d is e a s e s  th a t  o c c u r  m u c h  m o re  
f re q u e n tly . H o w e v e r , if a  p e rs o n  h a s  th e  c o n s te lla t io n  o f  s y m p to m s  d e s c r ib e d  a b o v e , a n d  in fe c tio n  w ith  E b o la  v iru s  is 
s u s p e c te d , is o la te  th e  p a t ie n t  a n d  n o tify  lo c a l a n d  s ta te  h e a lth  d e p a r tm e n ts  a n d  th e  C D C .
What laboratory tests are used to diagnose Ebola hemorrhagic fever?
A n t ig e n -c a p tu re  e n z y m e - l in k e d  im m u n o s o rb e n t  a s s a y  (E L IS A )  te s t in g , Ig M  E L IS A , p o ly m e r a s e  c h a in  re a c t io n  ( P C R ) ,  a n d  
v iru s  is o la tio n  c a n  b e  u s e d  to  d ia g n o s e  a  c a s e  o f  E b o la  H F  w ith in  a  fe w  d a y s  o f  th e  o n s e t  o f  s y m p to m s . P e rs o n s  te s te d  la te r  
in th e  c o u rs e  o f  th e  d is e a s e  o r  a f te r  re c o v e r y  c a n  b e  te s te d  fo r  Ig M  a n d  Ig G  a n tib o d ie s ;  th e  d is e a s e  c a n  a ls o  b e  d ia g n o s e d  
r e tro s p e c t iv e ly  in d e c e a s e d  p a t ie n ts  b y  u s in g  im m u n o h is to c h e m is try  te s t in g , v iru s  is o la tio n , o r  P C R .
How is Ebola hemorrhagic fever treated?
T h e r e  is n o  s ta n d a rd  t r e a tm e n t  fo r  E b o la  H F . P a t ie n ts  re c e iv e  s u p p o r t iv e  th e ra p y . T h is  c o n s is ts  o f b a la n c in g  th e  
p a tie n t 's  f lu id s  a n d  e le c tro ly te s , m a in ta in in g  th e ir  o x y g e n  s ta tu s  a n d  b lo o d  p re s s u re , a n d  tre a t in g  th e m  fo r  a n y  
c o m p lic a t in g  in fe c tio n s .
How is Ebola hemorrhagic fever prevented?
T h e  p re v e n tio n  o f  E b o la  H F  in A fr ic a  p re s e n ts  m a n y  c h a lle n g e s . B e c a u s e  th e  id e n tity  a n d  lo c a tio n  o f  th e  n a tu ra l  
re s e rv o ir  o f  E b o la  v iru s  a re  u n k n o w n , th e r e  a re  fe w  e s ta b l is h e d  p r im a ry  p re v e n tio n  m e a s u r e s .
If c a s e s  o f  th e  d is e a s e  d o  a p p e a r , c u r re n t  s o c ia l a n d  e c o n o m ic  c o n d it io n s  o fte n  fa v o r  th e  s p r e a d  o f  a n  e p id e m ic  w ith in  
h e a lth -c a r e  fa c ilit ie s . T h e r e fo r e ,  h e a lth -c a r e  p ro v id e rs  m u s t b e  a b le  to  r e c o g n iz e  a  c a s e  o f  E b o la  H F  s h o u ld  o n e  a p p e a r .  
T h e y  m u s t a ls o  h a v e  th e  c a p a b ili ty  to  p e r fo rm  d ia g n o s tic  te s ts  a n d  b e  r e a d y  to  e m p lo y  p ra c t ic a l v ira l h e m o r rh a g ic  fe v e r  
is o la tio n  p re c a u tio n s , o r  b a r r ie r  n u rs in g  te c h n iq u e s . T h e s e  te c h n iq u e s  in c lu d e  th e  w e a r in g  o f  p ro te c t iv e  c lo th in g , s u c h  a s  
m a s k s , g lo v e s , g o w n s , a n d  g o g g le s ; th e  u s e  o f  in fe c t io n -c o n tro l m e a s u r e s , in c lu d in g  c o m p le te  e q u ip m e n t  s te r il iz a tio n ; a n d  
th e  is o la tio n  o f  E b o la  H F  p a t ie n ts  fro m  c o n ta c t  w ith  u n p ro te c te d  p e rs o n s . T h e  a im  o f  a ll o f  th e s e  te c h n iq u e s  is to  a v o id  a n y  
p e rs o n 's  c o n ta c t  w ith  th e  b lo o d  o r  s e c re t io n s  o f  a n y  p a t ie n t . If  a  p a t ie n t  w ith  E b o la  H F  d ie s , it is e q u a lly  im p o rta n t  th a t  
d ire c t  c o n ta c t  w ith  th e  b o d y  o f  th e  d e c e a s e d  p a t ie n t  b e  p r e v e n te d .
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How is Ebola hemorrhagic fever prevented? (continued)
C D C  h a s  d e v e lo p e d  a  s e t  o f  to o ls  to  m e e t  h e a lth -c a r e  fa c ilit ie s ' n e e d s . In c o n ju n c t io n  w ith  th e  W o r ld  H e a lth  O r g a n iz a t io n ,  
C D C  h a s  d e v e lo p e d  p ra c tic a l, h o s p ita l-b a s e d  g u id e lin e s , e n t it le d  In fe c tio n  C o n tro l fo r  V ira l H a e m o r r h a g ic  F e v e rs  in th e  
A fr ic a n  H e a lth  C a r e  S e t t in g . T h e  m a n u a l d e s c r ib e s  h o w  to  r e c o g n iz e  c a s e s  o f  v ira l h e m o r rh a g ic  fe v e r , s u c h  a s  E b o la  H F ,  
a n d  p r e v e n t  fu r th e r  n o s o c o m ia l t ra n s m is s io n  b y  u s in g  lo c a lly  a v a i la b le  m a te r ia ls  a n d  fe w  f in a n c ia l re s o u rc e s . S im ila r ly , a  
p ra c t ic a l d ia g n o s tic  te s t  th a t  u s e s  t in y  s a m p le s  f ro m  p a t ie n ts ' sk in  h a s  b e e n  d e v e lo p e d  to  r e tro s p e c t iv e ly  d ia g n o s e  E b o la  
H F  in s u s p e c te d  c a s e -p a t ie n ts  w h o  h a v e  d ie d .
What challenges remain for the control and prevention of Ebola hemorrhagic fever?
S c ie n t is ts  a n d  re s e a rc h e r s  a r e  fa c e d  w ith  th e  c h a lle n g e s  o f  d e v e lo p in g  a d d it io n a l d ia g n o s tic  to o ls  to  a s s is t  in e a r ly  
d ia g n o s is  o f  E b o la  H F  a n d  c o n d u c tin g  e c o lo g ic a l in v e s t ig a t io n s  o f  E b o la  v iru s  a n d  its p o s s ib le  re s e rv o ir . In a d d it io n , o n e  o f  
th e  re s e a rc h  g o a ls  is to  m o n ito r  s u s p e c te d  a r e a s  to  d e te rm in e  th e  in c id e n c e  o f  th e  d is e a s e . M o r e  e x te n s iv e  k n o w le d g e  o f  
th e  n a tu ra l r e s e rv o ir  o f  E b o la  v iru s  a n d  h o w  th e  v iru s  is s p r e a d  m u s t b e  a c q u ire d  to  p re v e n t  fu tu re  o u tb re a k s  e ffe c t iv e ly .
U n s u r e  a b o u t  s o m e  o f  th e  te rm s  u s e d  a b o v e ?  S e e  th e  glossary o f terms e n c lo s e d  in th e  p a c k e t.
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For more information on viral hemorrhagic fevers, 
see the SPB web page at http://www.cdc.gov/ncidod/dvrd/spb/index.htm.
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Ebola Hemorrhagic Fever 
Case Count and Location List
Year Ebola
Species
Country No. o f Human 
Cases
Reported 




1 9 7 6 E b o la -Z a ir e Z a ir e 3 1 8 2 8 0 ( 8 8 % ) O c c u r re d  in Y a m b u k u  a n d  s u rro u n d in g  a re a .  
D is e a s e  w a s  s p r e a d  b y  c lo s e  p e rs o n a l c o n ta c t  a n d  
b y  u s e  o f  c o n ta m in a te d  n e e d le s  a n d  s y r in g e s  in 
h o s p ita ls /c lin ic s . T h is  w a s  th e  firs t re c o g n it io n  o f  th e  
d is e a s e .
1 9 7 6 E b o la ­
S u d a n
S u d a n 2 8 4 1 5 1 ( 5 3 % ) O c c u r re d  in N z a r a ,  M a r id i a n d  th e  s u rro u n d in g  
a re a . D is e a s e  w a s  s p r e a d  m a in ly  th ro u g h  c lo s e  
p e rs o n a l c o n ta c t  w ith in  h o s p ita ls . M a n y  m e d ic a l  
c a r e  p e rs o n n e l w e r e  in fe c te d .
1 9 7 6 E b o la ­
S u d a n
E n g la n d 1 0 ( 0 % ) L a b o ra to r y  in fe c tio n  b y  a c c id e n ta l s tic k  o f  
c o n ta m in a te d  n e e d le .
1 9 7 7 E b o la -Z a ir e Z a ir e 1 1 ( 1 0 0 % ) N o te d  r e t ro s p e c t iv e ly  in th e  v illa g e  o f T a n d a la .
1 9 7 9 E b o la ­
S u d a n
S u d a n 3 4 2 2 ( 6 5 % ) O c c u r re d  in N z a r a .  R e c u r r e n t  o u tb r e a k  a t th e  s a m e  
s ite  a s  th e  1 9 7 6  S u d a n  e p id e m ic .
1 9 8 9 E b o la -
R e s to n
U S A 0 0 ( 0 % ) E b o la -R e s to n  v iru s  w a s  in tro d u c e d  in to  q u a r a n t in e  
fa c ilit ie s  in V irg in ia  a n d  P e n n s y lv a n ia  b y  m o n k e y s  
im p o rte d  f ro m  th e  P h ilip p in e s .
1 9 9 0 E b o la -
R e s to n
U S A 4
(A sym ptom atic)
0 ( 0 % ) E b o la  w a s  in tro d u c e d  o n c e  a g a in  in to  q u a r a n t in e  
fa c ilit ie s  in V irg in ia  a n d  T e x a s  b y  m o n k e y s  im p o rte d  
f ro m  th e  P h ilip p in e s . F o u r  h u m a n s  d e v e lo p e d  









1 E b o la -
R e s to n
P h ilip p in e s 3
(asym ptom atic)
0 ( 0 % ) H ig h  m o r ta lity  a m o n g  c y n o m o lg u s  m a c a q u e s  in a  
p r im a te  fa c ility  re s p o n s ib le  fo r  e x p o r t in g  a n im a ls  in 
th e  U S A . T h r e e  w o rk e r s  in th e  a n im a l fa c ility  
d e v e lo p e d  a n t ib o d ie s  b u t d id  n o t g e t  s ick .
1 9 9 2 E b o la -
R e s to n
Ita ly 0 0 ( 0 % ) E b o la -R e s to n  w a s  in tro d u c e d  in to  q u a r a n t in e  
fa c ilit ie s  in S ie n n a  b y  m o n k e y s  im p o rte d  f ro m  th e  
s a m e  e x p o r t  fa c ility  in th e  P h ilip p in e s  th a t  w a s  
in v o lv e d  in th e  e p is o d e s  in th e  U n ite d  S ta te s . N o  
h u m a n s  w e r e  in fe c te d .
1 9 9 4 E b o la -Z a ir e G a b o n 5 2 3 1 ( 6 0 % ) O c c u r re d  in M e k o u k a  a n d  o th e r  g o ld -m in in g  c a m p s  
d e e p  in th e  ra in  fo re s t. In itia lly  th o u g h t  to  b e  y e l lo w  
F e v e r;  id e n tif ie d  a s  E b o la  h e m o r rh a g ic  fe v e r  in 
1 9 9 5 .
1 9 9 4 E b o la - Iv o r y
C o a s t
Iv o ry  C o a s t 1 0 ( 0 % ) S c ie n t is t  b e c a m e  ill a f te r  c o n d u c tin g  a n  a u to p s y  on  
a  w ild  c h im p a n z e e  in th e  T a i  F o re s t . T h e  p a t ie n t  
w a s  t r e a te d  in S w itz e r la n d .
1 9 9 5 E b o la -Z a ir e Z a ir e 3 1 5 2 5 0 ( 8 1 % ) O c c u r re d  in K ik w i a n d  s u rro u n d in g  a re a . T r a c e d  to  
in d e x  c a s e -p a t ie n t  w h o  w o rk e d  in fo re s t  a d jo in in g  
th e  c ity . E p id e m ic  s p r e a d  th ro u g h  fa m ilie s  a n d  
h o s p ita ls .
1 9 9 6
(J a n -A p r )
E b o la -Z a ir e G a b o n 3 7 2 1 ( 5 7 % ) O c c u r re d  in M a y ib o u t  a re a . A  c h im p a n z e e  fo u n d  
d e a d  in th e  fo re s t  w a s  e a te n  b y  p e o p le  h u n tin g  fo r  
fo o d . N in e te e n  p e o p le  w h o  w e r e  in v o lv e d  in th e  
b u tc h e ry  o f  th e  a n im a l b e c a m e  ill; o th e r  c a s e s  
o c c u rre d  in fa m ily  m e m b e rs .
1 9 9 6
(J u l-J a n )
E b o la -Z a ir e G a b o n 6 0 4 5 ( 7 4 % ) O c c u r re d  in B o o u e  a r e a  w ith  t ra n s p o r t  o f  p a t ie n ts  to  
L ib re v ille . In d e x  c a s e -p a t ie n t  w a s  a  h u n te r  w h o  
live d  in a  fo r e s t  c a m p . D is e a s e  w a s  s p r e a d  b y  c lo s e  
c o n ta c t  w ith  in fe c te d  p e rs o n s . A  d e a d  c h im p a n z e e  
fo u n d  in th e  fo r e s t  a t  th e  t im e  w a s  d e te rm in e d  to  b e  
in fe c te d .
1 9 9 6 E b o la -Z a ir e S o u th
A fr ic a
2 1 ( 5 0 % ) A  m e d ic a l p r o fe s s io n a l t r a v e le d  fro m  G a b o n  to  
J o h a n n e s b u rg , S o u th  A fr ic a , a f te r  h a v in g  t r e a te d  
E b o la  v iru s - in fe c te d  p a t ie n ts  a n d  th u s  h a v in g  b e e n  
e x p o s e d  to  th e  v iru s  th e r e . H e  w a s  h o s p ita liz e d ,  
a n d  a  n u rs e  w h o  to o k  c a r e  o f  h im  b e c a m e  in fe c te d  
a n d  d ie d .
Year Ebola
Species
Country No. o f Human 
Cases
Reported 




1 9 9 6 E b o la -
R e s to n
U S A 0 0 ( % ) E b o la -R e s to n  v iru s  w a s  in tro d u c e d  in to  a  
q u a r a n t in e  fa c ility  in T e x a s  b y  m o n k e y s  im p o rte d  
f ro m  th e  P h ilip p in e s . N o  h u m a n  in fe c tio n s  w e r e  
id e n tif ie d .
1 9 9 6 E b o la -
R e s to n
P h ilip p in e s 0 0 ( 0 % ) E b o la -R e s to n  v iru s  w a s  id e n tif ie d  in a  m o n k e y  
e x p o r t  fa c ility  in th e  P h ilip p in e s . N o  h u m a n  
in fe c tio n s  w e r e  id e n tif ie d .
2 0 0 0 ­
2 0 0 1
E b o la -S u d a n U g a n d a 4 2 5 2 2 4 ( 5 3 % ) O c c u r re d  in G u lu , M a s in d i, a n d  M b a r a r a  d is tr ic ts  o f  
U g a n d a . T h e  th r e e  m o s t im p o rta n t  ris k s  a s s o c ia te d  
w ith  E b o la  v iru s  in fe c tio n  w e r e  a tte n d in g  fu n e r a ls  o f  
E b o la  h e m o r rh a g ic  c a s e -p a t ie n ts , h a v in g  c o n ta c t  
w ith  c a s e -p a t ie n ts  in o n e 's  fa m ily , a n d  p ro v id in g  
m e d ic a l c a r e  to  E b o la  c a s e -p a t ie n ts  w ith o u t  
a d e q u a te  p e rs o n a l p ro te c t iv e  m e a s u r e s .
2 0 0 1 ­
2 0 0 1
( 0 c t '0 1 -
M a r '0 2 )
E b o la -Z a ir e G a b o n 6 5 5 3 ( 8 2 % ) O u tb r e a k  o c c u rre d  o v e r  th e  b o rd e r  o f  G a b o n  a n d  
th e  R e p u b lic  o f  th e  C o n g o .
2 0 0 1 ­
2 0 0 2
( 0 c t '0 1 -
M a r '0 2 )
E b o la -Z a ir e R e p u b lic  o f  
th e  C o n g o
5 7 4 3 ( 7 5 % ) O u tb r e a k  o c c u rre d  o v e r  th e  b o rd e r  o f  G a b o n  a n d  
th e  R e p u b lic  o f  th e  C o n g o . T h is  w a s  th e  firs t t im e  
E b o la  h e m o r rh a g ic  fe v e r  w a s  re p o r te d  in th e  
R e p u b lic  o f  th e  C o n g o .
2 0 0 2 ­
2 0 0 3
( D e c '0 2 -
A p r '0 3 )
E b o la -Z a ir e R e p u b lic  o f  
C o n g o
1 4 3 1 2 8 ( 8 9 % ) O u tb r e a k  o c c u rre d  in th e  d is tr ic ts  o f  M b o m o  a n d  
K é llé  in C u v e t te  O u e s t  D é p a r te m e n t .
2 0 0 3
(N o v -
D e c )
E b o la -Z a ir e R e p u b lic  o f  
C o n g o
3 5 2 9 ( 8 3 % ) O u tb r e a k  o c c u rre d  in M b o m o  a n d  M b a n d z a  
v il la g e s  lo c a te d  in th e  M b o m o  d is tr ic t, C u v e t te  
O u e s t  D é p a r te m e n t
2 0 0 4 E b o la -S u d a n S u d a n 1 7 7 ( 4 1 % ) O u tb r e a k  o c c u rre d  in Y a m b io  c o u n ty  o f  s o u th e rn  
S u d a n . T h is  w a s  c o n c u r re n t  w ith  a n  o u tb r e a k  o f 
m e a s le s  in th e  s a m e  a re a , a n d  s e v e r a l s u s p e c te d  
E H F  c a s e s  w e r e  la te r  re c la s s if ie d  a s  m e a s le s  
c a s e s .
2 0 0 7 E b o la -Z a ir e D e m o c r a t ic  
R e p u b lic  o f  
th e  C o n g o
2 6 4 1 8 7 ( 7 1 % ) O u tb r e a k  o c c u rre d  in K a s a i O c c id e n ta l P ro v in c e .  
T h e  o u tb r e a k  w a s  d e c la r e d  o v e r  N o v e m b e r  2 0 .  
L a s t c o n firm e d  c a s e  o n  O c to b e r  4  a n d  la s t d e a th  
o n  O c to b e r  1 0 .
D e c  2 0 0 7
-J a n
2 0 0 8
E b o la -
B u n d ib u g y o
U g a n d a 1 4 9 3 7 ( 2 5 % ) O u tb r e a k  o c c u rre d  in B u n d ib u g y o  D is tr ic t in 
U g a n d a . F irs t re p o r te d  o c c u r re n c e  o f  a  n e w  s tra in .
N o v  2 0 0 8 E b o la -
R e s to n
P h ilip p in e s 6
(a s y m p to m a t ic )
0 ( 0 % ) F irs t k n o w n  o c c u r re n c e  o f  E b o la -R e s to n  in p igs . 
S tra in  c lo s e ly  re la te d  to  e a r l ie r  s tra in s . S ix  w o rk e rs  
f ro m  th e  pig  fa rm  a n d  s la u g h te r h o u s e  d e v e lo p e d  
a n t ib o d ie s  b u t d id  n o t b e c o m e  s ick .
D e c  
2 0 0 8 -  
F e b  2 0 0 9
E b o la -Z a ir e D e m o c r a t ic  
R e p u b lic  o f  
th e  C o n g o
3 2 1 5 ( 4 7 % ) O u tb r e a k  o c c u rre d  in th e  M w e k a  a n d  L u e b o  h e a lth  
z o n e s  o f  th e  P ro v in c e  o f  K a s a i O c c id e n ta l .
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CENTERS FOR DISEASE CONTROL 
_______ AND PREVENTION________
Glossary of Terms
B e lo w  y o u  w ill fin d  a n  a lp h a b e t ic a l lis ting  o f  c o m m o n  te rm s  u s e d  in a r t ic le s  a b o u t  v ira l h e m o r rh a g ic  fe v e rs . T h e s e  te rm s  o c c u r  
f r e q u e n t ly  in e p id e m io lo g ic a l a n d  h e a lth  p re v e n tio n  li te ra tu re .
aerosol:
A  f in e  m is t o r  s p ra y  w h ic h  c o n ta in s  m in u te  p a r tic le s . 
antibody:
P ro te in s  p r o d u c e d  b y  a n  o rg a n is m 's  im m u n e  s y s te m  to  r e c o g n iz e  fo re ig n  s u b s ta n c e s .
antigen:
A n y  s u b s ta n c e  th a t  s t im u la te s  a n  im m u n e  r e s p o n s e  b y  th e  b o d y . T h e  im m u n e  s y s te m  re c o g n iz e s  s u c h  s u b s ta n c e s  a s  b e in g  
fo re ig n , a n d  p ro d u c e s  c e l lu la r  a n t ib o d ie s  to  f ig h t th e m . A n t ig e n /a n t ib o d y  r e s p o n s e  is a n  im p o rta n t  p a r t  o f  a  p e rs o n 's  
im m u n ity  to  d is e a s e .
assay:
Q u a n t ita t iv e  o r  q u a l ita t iv e  e v a lu a t io n , o r  te s t, o f  a  s u b s ta n c e . F r e q u e n t ly  u s e d  to  d e s c r ib e  te s ts  o f  th e  p r e s e n c e  o r  
c o n c e n tra tio n  o f  in fe c tio u s  a g e n ts , a n t ib o d ie s , e tc .
biosafety level:
S p e c if ic  c o m b in a t io n s  o f  w o rk  p ra c t ic e s , s a fe ty  e q u ip m e n t , a n d  fa c ilit ie s , w h ic h  a re  d e s ig n e d  to  m in im iz e  th e  e x p o s u r e  o f  
w o rk e r s  a n d  th e  e n v ir o n m e n t  to  in fe c tio u s  a g e n ts . B io s a fe ty  le v e l 1 a p p lie s  to  a g e n ts  th a t  d o  n o t o rd in a r ily  c a u s e  h u m a n  
d is e a s e . B io s a fe ty  le v e l 2  is a p p r o p r ia te  fo r  a g e n ts  th a t  c a n  c a u s e  h u m a n  d is e a s e , b u t w h o s e  p o te n tia l fo r  t ra n s m is s io n  is 
lim ite d . B io s a fe ty  le v e l 3  a p p lie s  to  a g e n ts  th a t  m a y  b e  t ra n s m it te d  b y  th e  re s p ira to ry  ro u te  w h ic h  c a n  c a u s e  s e r io u s  
in fe c tio n . B io s a fe ty  le v e l 4  is u s e d  fo r  th e  d ia g n o s is  o f e x o t ic  a g e n ts  th a t  p o s e  a  h ig h  r is k  o f  l i fe - th re a te n in g  d is e a s e , w h ic h  
m a y  b e  tr a n s m it te d  b y  th e  a e ro s o l ro u te  a n d  fo r  w h ic h  th e r e  is n o  v a c c in e  o r  th e ra p y .
carrier:
A  p e rs o n  o r  a n im a l th a t  h a rb o rs  a  s p e c if ic  in fe c tio u s  a g e n t  w ith o u t  v is ib le  s y m p to m s  o f  th e  d is e a s e . A  c a r r ie r  a c ts  a s  a  
p o te n t ia l s o u rc e  o f  in fe c tio n .
case-fatality proportion:
T h e  n u m b e r  o f  c a s e s  o f  a  d is e a s e  e n d in g  in d e a th  c o m p a re d  to  th e  n u m b e r  o f  c a s e s  o f  th e  d is e a s e . U s u a lly  e x p re s s e d  a s  a  
p e r c e n ta g e . W h ile  d e a th s  f ro m  o th e r  d is e a s e s  a re  o fte n  e x p re s s e d  a s  m o r ta lity  ra te s , S P B  n o rm a lly  u s e s  c a s e - fa ta l ity  
p ro p o rtio n s . T h e  is d u e  to  th e  fa c t  th a t  ra te s  in c lu d e  a  t im e  d e te rm in a n t  -  fo r  e x a m p le , 1 0 0  d e a th s  p e r  1 0 0 0  c a s e s  p e r  y e a r .  
H o w e v e r , th e  d is e a s e s  w ith  w h ic h  S P B  w o rk s  b r e a k  o u t s p o ra d ic a lly , a n d  o c c u r  a s  b r ie f  e p id e m ic s .
case-to-infection ratio or proportion:
T h e  n u m b e r  o f  c a s e s  o f  a  d is e a s e  (in  h u m a n s )  c o m p a re d  to  th e  n u m b e r  o f  in fe c tio n s  w ith  th e  a g e n t  th a t  c a u s e s  th e  d is e a s e  
(in  h u m a n s ) .
disease:
F o rm a lly  s p e a k in g , a  d is e a s e  is th e  c o n d it io n  in w h ic h  th e  fu n c tio n in g  o f  th e  b o d y  o r  a  p a r t  o f  th e  b o d y  is in te r fe re d  w ith  o r  
d a m a g e d . In a  p e rs o n  w ith  a n  in fe c tio u s  d is e a s e , th e  in fe c tio u s  a g e n t  th a t  h a s  e n te re d  th e  b o d y  c a u s e s  it to  fu n c tio n  
a b n o rm a lly  in s o m e  w a y  o r  w a y s . T h e  ty p e  o f  a b n o rm a l fu n c t io n in g  th a t  o c c u rs  is th e  d is e a s e . U s u a l ly  th e  b o d y  w ill s h o w  
s o m e  s ig n s  a n d  s y m p to m s  o f  th e  p ro b le m s  it is h a v in g  w ith  fu n c tio n in g . D is e a s e  s h o u ld  n o t b e  c o n fu s e d  w ith  in fe c tio n .
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ELISA (enzyme-linked-immunosorbent serologic assay):
A  te c h n iq u e  th a t  re lie s  o n  a n  e n z y m a t ic  c o n v e rs io n  re a c t io n . It is u s e d  to  d e te c t  th e  p r e s e n c e  o f  s p e c if ic  s u b s ta n c e s , s u c h  
a s  e n z y m e s , v iru s e s , a n t ib o d ie s  o r  b a c te r ia .
endemic:
D is e a s e  th a t  is w id e s p r e a d  in a  g iv e n  p o p u la tio n . 
enzootic:
A  d is e a s e  w h ic h  is c o n s ta n t ly  p r e s e n t  in th e  a n im a l c o m m u n ity , b u t o n ly  o c c u rs  in a  s m a ll n u m b e r  o f  c a s e s .
epidemic:
T h e  o c c u r re n c e  o f  c a s e s  o f  a n  il ln e s s  in a  c o m m u n ity  o r  re g io n  w h ic h  is in e x c e s s  o f  th e  n u m b e r  o f  c a s e s  n o rm a lly  e x p e c te d  
fo r  th a t  d is e a s e  in th a t  a r e a  a t  th a t  t im e .
epizootic:
A n  o u tb r e a k  o r  e p id e m ic  o f  d is e a s e  in a n im a l p o p u la t io n s .
host:
A n  o rg a n is m  in w h ic h  a  p a r a s ite  liv e s  a n d  b y  w h ic h  it is n o u r is h e d .
IgG:
O n e  o f  m a n y  a n t ib o d ie s  p r e s e n t  in b lo o d  s e r u m  w h ic h  is u s u a lly  in d ic a t iv e  o f  a  r e c e n t  o r  r e m o te  in fe c tio n . Ig G  is m o s t  
p r e v a le n t  a b o u t  3  w e e k s  a f te r  a n  in fe c tio n  b e g in s .
IgM:
O n e  o f  m a n y  a n t ib o d ie s  p re s e n t  in b lo o d  s e r u m  w h ic h  is u s u a lly  in d ic a t iv e  o f  a n  a c u te  in fe c tio n . 
immunohistochem istry:
A  ty p e  o f  a s s a y  in w h ic h  s p e c if ic  a n t ig e n s  a r e  m a d e  v is ib le  b y  th e  u s e  o f  f lu o r e s c e n t  d y e  o r  e n z y m e  m a rk e rs .
infection:
T h e  e n try  a n d  d e v e lo p m e n t  o f  a n  in fe c tio u s  a g e n t  in th e  b o d y  o f  a  p e rs o n  o r  a n im a l. In a n  a p p a r e n t  " m a n ife s t"  in fe c tio n , th e  
in fe c te d  p e rs o n  o u tw a rd ly  a p p e a r s  to  b e  s ic k . In a n  a p p a r e n t  in fe c tio n , th e r e  is no  o u tw a rd  s ig n  th a t  a n  in fe c tio u s  a g e n t  h a s  
e n te re d  th a t  p e rs o n  a t  a ll. F o r  e x a m p le , a lth o u g h  h u m a n s  h a v e  b e c o m e  in fe c te d  w ith  E b o la -R e s to n , a  s p e c ie s  o f E b o la  
v iru s , th e y  h a v e  n o t s h o w n  a n y  s ig n  o f  illn e s s . B y  c o n tra s t, in re c o rd e d  o u tb r e a k s  o f  E b o la  h e m o r rh a g ic  fe v e r  c a u s e d  by  
E b o la -Z a ir e ,  a n o th e r  s p e c ie s  o f  E b o la  v iru s , s e v e r e  il ln e s s  fo llo w e d  in fe c tio n  w ith  th e  v iru s , a n d  a  g r e a t  p ro p o rtio n  o f  th e  
c a s e -p a t ie n ts  d ie d . In fe c tio n  s h o u ld  n o t b e  c o n fu s e d  w ith  d is e a s e .
noscomial infection:
A n  in fe c tio n  o c c u rr in g  in a  p a t ie n t  w h ic h  is a c q u ire d  a t a  h o s p ita l o r  o th e r  h e a lth c a r e  fa c ility . C o m m o n ly  c a lle d  a  c ro s s  
in fe c tio n .
report o f a disease:
A n  o ffic ia l re p o r t  th a t  n o tif ie s  a n  a p p r o p r ia te  h e a lth  a u th o r ity  o f  th e  o c c u r re n c e  o f  a  d is e a s e  in a  h u m a n  o r  in a n  a n im a l.  
H u m a n  d is e a s e s  u s u a lly  a re  re p o r te d  firs t to  th e  lo c a l h e a lth  a u th o rity , s u c h  a s  a  c o u n ty  h e a lth  d e p a r tm e n t .
reservoir:
A n y  p e rs o n , a n im a l,  a r th ro p o d , p la n t, so il o r  s u b s ta n c e  in w h ic h  a n  in fe c tiv e  a g e n t  n o rm a lly  liv e s  a n d  m u ltip lie s . T h e  
in fe c tio u s  a g e n t  p r im a r ily  d e p e n d s  o n  th e  r e s e rv o ir  fo r  its s u rv iv a l.
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risk:
A )  T h e  c h a n c e  o f  b e in g  e x p o s e d  to  a n  in fe c tio u s  a g e n t  b y  its s p e c if ic  t ra n s m is s io n  m e c h a n is m .
B ) T h e  c h a n c e  o f  b e c o m in g  in fe c te d  if e x p o s e d  to  a n  in fe c tio u s  a g e n t  b y  its s p e c if ic  t ra n s m is s io n  m e c h a n is m .
RT-PCR (reverse transcriptase polymerase chain reaction):
P o w e r fu l te c h n iq u e  fo r  p ro d u c in g  m illio n s  o f  c o p ie s  o f  s p e c if ic  p a r ts  o f  th e  g e n e t ic  c o d e  o f  a n  o rg a n is m  s o  th a t  it m a y  b e  
re a d i ly  a n a ly z e d . M o r e  s p e c if ic a lly , R T - P C R  p ro d u c e s  c o p ie s  o f  a  s p e c if ic  re g io n  o f  c o m p le m e n ta ry  D N A  th a t  h a s  b e e n  
c o n v e r te d  f ro m  R N A . T h e  te c h n iq u e  is o fte n  u s e d  to  h e lp  in th e  id e n tif ic a tio n  o f  a n  in fe c tio u s  a g e n t.
surveillance o f disease:
T h e  o n g o in g  s y s te m a t ic  c o lle c t io n  a n d  a n a ly s is  o f  d a ta  a n d  th e  p ro v is io n  o f  in fo rm a tio n  w h ic h  le a d s  to  a c tio n  b e in g  ta k e n  to  
p re v e n t  a n d  c o n tro l a n  in fe c tio u s  d is e a s e .
transm ission o f infectious agents (such as a virus):
A n y  m e c h a n is m  th ro u g h  w h ic h  a n  in fe c tio u s  a g e n t , s u c h  a s  a  v iru s , is s p r e a d  fro m  a  re s e r v o ir  (o r  s o u rc e )  to  a  h u m a n  b e in g .  
U s u a lly  e a c h  ty p e  o f  in fe c tio u s  a g e n t  is s p r e a d  b y  o n ly  o n e  o r  a  fe w  o f  th e  d if fe re n t  m e c h a n is m s .
There are several types o f transm ission mechanisms: 
a) Direct transmission:
T h is  ty p e  o f  tra n s m is s io n  is, a t  b a s e , im m e d ia te . T h e  t r a n s fe r  o f  th e  in fe c tio u s  a g e n t  is, a s  th e  n a m e  im p lie s , 
d ire c t ly  in to  th e  b o d y . D if fe re n t  in fe c tio u s  a g e n ts  m a y  e n te r  th e  b o d y  u s in g  d if fe re n t  ro u te s . S o m e  ro u te s  b y  w h ic h  
in fe c tio u s  d is e a s e s  a r e  s p r e a d  d ire c t ly  in c lu d e  p e rs o n a l c o n ta c t , s u c h  a s  to u c h in g , b itin g , k is s in g  o r  s e x u a l  
in te rc o u rs e . In th e s e  c a s e s  th e  a g e n t  e n te rs  th e  b o d y  th ro u g h  th e  s k in , m o u th , a n  o p e n  c u t o r  s o re , o r  s e x u a l  
o rg a n s . In fe c tio u s  a g e n ts  m a y  s p r e a d  b y  t in y  d ro p le ts  o f  s p ra y  d ire c t ly  in to  th e  c o n ju n c t iv a  ( th e  m u c u s  m e m b r a n e s  
o f  th e  e y e ) ,  o r  th e  n o s e  o r  m o u th  d u rin g  s n e e z in g , c o u g h in g , s p ittin g , s in g in g  o r  ta lk in g  (a lth o u g h  u s u a lly  th is  ty p e  
o f  s p r e a d  is lim ite d  to  a b o u t  w ith in  o n e  m e te r 's  d is ta n c e .)  T h is  is c a lle d  d ro p le t  s p re a d .
b) Indirect transm ission:
In d ire c t  tra n s m is s io n  m a y  h a p p e n  in a n y  o f  s e v e r a l w a y s :
Vehicle-borne transm ission:
In th is  s itu a tio n , a  v e h ic le — th a t  is, a n  in a n im a te  o b je c t  o r  m a te r ia l c a lle d  in s c ie n tif ic  te rm s  a  
" fo m ite "— b e c o m e s  c o n ta m in a te d  w ith  th e  in fe c tio u s  a g e n t . T h e  a g e n t, s u c h  a s  a  v iru s , m a y  o r  
m a y  n o t h a v e  m u lt ip lie d  o r  d e v e lo p e d  in o r  o n  th e  v e h ic le . T h e  v e h ic le  c o n ta c ts  th e  p e rs o n 's  b o d y .
It m a y  b e  in g e s te d  (e a te n  o r  d ru n k ) , to u c h  th e  s k in , o r  b e  in tro d u c e d  in te rn a lly  d u rin g  s u r g e ry  o r  
m e d ic a l t r e a tm e n t . E x a m p le s  o f  v e h ic le s  th a t  c a n  t r a n s m it  d is e a s e s  in c lu d e  c o o k in g  o r  e a t in g  
u te n s ils , b e d d in g  o r  c lo th in g , to y s , s u rg ic a l o r  m e d ic a l in s tru m e n ts  ( lik e  c a th e te r s )  o r  d re s s in g s .
W a te r ,  fo o d , d r in k s  ( lik e  m ilk ) a n d  b io lo g ic a l p ro d u c ts  lik e  b lo o d , s e ru m , p la s m a , t is s u e s  o r  o rg a n s  
c a n  a ls o  b e  v e h ic le s .
Vector-borne transmission:
W h e n  re s e a rc h e r s  ta lk  a b o u t  v e c to rs , o fte n  th e y  a re  ta lk in g  a b o u t  in s e c ts , w h ic h  a s  a  g ro u p  o f  
in v e r te b r a te  a n im a ls  c a r ry  a  h o s t o f  d if fe re n t  in fe c tio u s  a g e n ts . (H o w e v e r ,  a  v e c to r  c a n  b e  a n y  
liv ing  c re a tu r e  th a t  tra n s m its  a n  in fe c tio u s  a g e n t  to  h u m a n s .)
V e c to rs  m a y  m e c h a n ic a l ly  s p re a d  th e  in fe c tio u s  a g e n t , s u c h  a s  a  v iru s  o r  p a ra s ite . In th is  s c e n a r io  th e  
v e c to r — fo r  in s ta n c e  a  m o s q u ito —  c o n ta m in a te s  its fe e t  o r  p ro b o s c is  (" n o s e " )  w ith  th e  in fe c tio u s  a g e n t, o r  
th e  a g e n t  p a s s e s  th ro u g h  its g a s tro in te s t in a l t ra c t. T h e  a g e n t  is tr a n s m it te d  fro m  th e  v e c to r  w h e n  it b ite s  
o r  to u c h e s  a  p e rs o n . In th e  c a s e  o f  a n  in s e c t, th e  in fe c tio u s  a g e n t  m a y  b e  in je c te d  w ith  th e  in s e c t's  
s a l iv a ry  flu id  w h e n  it b ite s . O r  th e  in s e c t  m a y  re g u rg ita te  m a te r ia l o r  d e p o s it  fe c e s  on  th e  s k in , w h ic h  th e n  
e n te r  a  p e rs o n 's  b o d y , ty p ic a lly  th ro u g h  a  b ite  w o u n d  o r  s k in  th a t  h a s  b e e n  b ro k e n  b y  s c ra tc h in g  o r  
ru b b in g . In th e  c a s e  o f  s o m e  in fe c tio u s  a g e n ts , v e c to rs  a re  o n ly  c a p a b le  o f  t ra n s m itt in g  th e  d is e a s e  d u rin g  
a  c e r ta in  t im e  p e r io d . In th e s e  s itu a tio n s ,
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Vector-borne transm ission (continued):
v e c to rs  p la y  h o s t to  th e  a g e n t . T h e  a g e n t  n e e d s  th e  h o s t to  d e v e lo p  a n d  m a tu re  o r  to  re p ro d u c e  
(m u lt ip ly )  o r  b o th  (c a lle d  c y c lo p r o p a g a t iv e ) .  O n c e  th e  a g e n t  is w ith in  th e  v e c to r  a n im a l, a n  
in c u b a tio n  p e r io d  fo llo w s  d u rin g  w h ic h  th e  a g e n t  g ro w s  o r  r e p ro d u c e s , o r  b o th , d e p e n d in g  o n  th e  
ty p e  o f  a g e n t . O n ly  a f te r  th is  p h a s e  is o v e r  d o e s  th e  v e c to r  b e c o m e  in fe c tiv e . T h a t  is, o n ly  th e n  
c a n  it t r a n s m it  a n  a g e n t  th a t  is c a p a b le  o f  c a u s in g  d is e a s e  in th e  p e rs o n .
c) Airborne transmission:
In th is  ty p e  o f  tra n s m is s io n , in fe c t iv e  a g e n ts  a re  s p r e a d  a s  a e ro s o ls , a n d  u s u a lly  e n te r  a  p e rs o n  th ro u g h  th e  
re s p ira to ry  tra c t. A e r o s o ls  a re  t in y  p a r tic le s , c o n s is tin g  in p a r t  o r  c o m p le te ly  o f  th e  in fe c tio u s  a g e n t  itse lf, w h ic h  
b e c o m e  s u s p e n d e d  in th e  a ir . T h e s e  p a r t ic le s  m a y  re m a in  s u s p e n d e d  in th e  a ir  fo r  lo n g  p e r io d s  o f  t im e , a n d  
s o m e  re ta in  th e ir  a b ility  to  c a u s e  d is e a s e , w h ile  o th e rs  d e g e n e r a te  d u e  to  th e  e ffe c ts  o f  s u n lig h t, d ry n e s s  o r  o th e r  
c o n d it io n s . W h e n  a  p e rs o n  b r e a th e s  in th e s e  p a rtic le s , th e y  b e c o m e  in fe c te d  w ith  th e  a g e n t— e s p e c ia l ly  in th e  
a lv e o li o f  th e  lu n g s . (s e e  a ls o  " a e ro s o liz a t io n " )
How do infectious aerosols get into the air?
S m a ll p a r tic le s  o f m a n y  d if fe re n t  s iz e s  c o n ta m in a te d  w ith  th e  in fe c t iv e  a g e n t  m a y  r is e  u p  fro m  so il, c lo th e s ,  
b e d d in g  o r  flo o rs  w h e n  th e s e  a re  m o v e d , c le a n e d  o r  b lo w n  b y  w in d . T h e s e  d u s t p a r tic le s  m a y  b e  fu n g a l s p o r e s —  
in fe c tiv e  a g e n ts  t h e m s e lv e s — tin y  b its  o f  in fe c te d  fe c e s , o r  t in y  p a r t ic le s  o f  d irt o r  so il th a t  h a v e  b e e n  
c o n ta m in a te d  w ith  th e  a g e n t.
D ro p le t  n u c le i c a n  re m a in  in th e  a ir  fo r  a  lo n g  t im e . D ro p le t  n u c le i a re  u s u a lly  th e  s m a ll re s id u e s  th a t  a p p e a r  w h e n  
flu id  e m it te d  f ro m  a n  in fe c te d  h o s t e v a p o r a te s . In th e  c a s e  o f  th e  v iru s  c a u s in g  h a n ta v iru s  p u lm o n a ry  s y n d ro m e ,  
th e  ro d e n t  c a r r ie rs  p ro d u c e  u r in e . T h e  a c t  o f  s p ra y in g  th e  u r in e  m a y  c re a te  th e  a e ro s o ls  d ire c tly , o r  th e  v iru s  
p a r tic le s  m a y  r is e  in to  th e  a ir  a s  th e  u r in e  e v a p o r a te s . In o th e r  s itu a tio n s , th e  d ro p le ts  m a y  o c c u r  a s  a n  u n in te n d e d  
re s u lt  o f  m e c h a n ic a l o r  w o rk  p r o c e s s e s  o r  a to m iz a t io n  b y  h e a t in g , c o o lin g , o r  v e n t in g  s y s te m s  in m ic ro b io lo g y  
la b o ra to r ie s , a u to p s y  ro o m s , s la u g h te r h o u s e s  o r  e ls e w h e r e .
B o th  k in d s  o f  p a r t ic le s  a r e  v e r y  tin y . L a r g e r  d ro p le ts  o r  o b je c ts  th a t  m a y  b e  s p r a y e d  o r  b lo w n  b u t th a t  
im m e d ia te ly  s e tt le  d o w n  o n  s o m e th in g  r a th e r  th a n  r e m a in in g  s u s p e n d e d , a r e  n o t c o n s id e re d  to  b e lo n g  to  th e  
a irb o rn e  t ra n s m is s io n  m e c h a n is m . S u c h  s p ra y s  a r e  c o n s id e re d  d ire c t  t ra n s m is s io n .
vector:
A  c a r r ie r  w h ic h  tra n s m its  in fe c t iv e  a g e n t  fro m  o n e  h o s t to  a n o th e r .
virus:
A  v iru s  is a n  e x t r e m e ly  t in y  in fe c tio u s  a g e n t  th a t  is o n ly  a b le  to  liv e  in s id e  a  c e ll. B a s ic a lly , v iru s e s  a re  c o m p o s e d  o f  ju s t  tw o  
p a rts . T h e  o u te r  p a r t  is a  p ro te c t iv e  s h e ll m a d e  o f p ro te in . T h is  s h e ll is o fte n  s u r ro u n d e d  b y  a n o th e r  p ro te c t iv e  la y e r  o r  
e n v e lo p e , m a d e  o f  p ro te in  o r  lip id s  ( fa ts ) . T h e  in n e r  p a r t  is m a d e  o f  g e n e t ic  m a te r ia l, e ith e r  R N A  o r  D N A . A  v iru s  d o e s  no t  
h a v e  a n y  o th e r  s tru c tu re s  (c a l le d  o r g a n e lle s )  th a t  liv ing  c e lls  h a v e , like  a  n u c le u s  o r  m ito c h o n d r ia . T h e s e  o r g a n e lle s  a r e  th e  
t in y  o rg a n s  th a t  m a in ta in  a  c e ll's  m e ta b o lis m  (life  p r o c e s s e s ) . A  v iru s  h a s  n o  m e ta b o lis m  a t  a ll.
B e c a u s e  a  v iru s  la c k s  o rg a n e lle s , it c a n n o t  r e p ro d u c e  its e lf  b y  itse lf. T o  re p ro d u c e , it in v a d e s  a  c e ll w ith in  th e  b o d y  o f  a  
h u m a n  o r  o th e r  c re a tu re , c a l le d  th e  h o s t. E a c h  ty p e  o f  v iru s  h a s  p a r t ic u la r  ty p e s  o f  h o s t c re a tu r e s  a n d  h o s t c e lls  th a t  it w ill 
in v a d e  s u c c e s s fu lly .
O n c e  w ith in  th e  h o s t c e ll, th e  v iru s  u s e s  th e  c e ll's  o w n  o r g a n e lle s  to  p r o d u c e  m o re  v iru s e s . In e s s e n c e , th e  v iru s  fo rc e s  
th e  c e ll to  re p lic a te  th e  v iru s ' o w n  g e n e t ic  m a te r ia l a n d  p ro te c t iv e  s h e ll. O n c e  re p lic a te d , th e  n e w  v iru s e s  le a v e  th e  h o s t  
c e ll a n d  a re  r e a d y  to  in v a d e  o th e rs .
zoonotic disease or infection:
A n  in fe c tio n  o r  in fe c tio u s  d is e a s e  th a t  m a y  b e  t r a n s m it te d  fro m  v e r te b r a te  a n im a ls  (s u c h  a s  a  r o d e n t)  to  h u m a n s .
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